Business Context and Reporting Period
This Form 8-K was filed by IRIDEX Corporation on December 15, 2017. The report discloses the approval of the Company's 2018 Short-Term Incentive Plan (STI Plan) by the Board of Directors, based on a recommendation from the Compensation Committee.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The primary material event is the establishment of the 2018 STI Plan. Eligible participants include Mr. Moore and Mr. Mokari. The plan ties compensation to the achievement of corporate sales targets and specific individual financial and operational performance goals.
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance, market outlook, or discussion of general business risks. The only contingent items disclosed are the performance conditions required for executive payouts under the STI Plan.
Executive Compensation Details
- Mr. Moore: Maximum payable amount is $382,388.
- Mr. Mokari: Maximum payable amount is $213,500.
Investor Verification Checklist
- Verify the specific sales targets and operational goals defined in the 2018 STI Plan.
- Confirm the total number of participants eligible for the STI Plan beyond Mr. Moore and Mr. Mokari.
- Review the Company's most recent 10-K or 10-Q for actual financial performance against the targets mentioned in this plan.